The present study was designed to compare the functional outcome of the intraspinal transplantation of CD34+ human umbilical cord blood (CB) cells with that of human bone marrow stromal (BMS) cells in adult rats with spinal cord injury. Sixty adult Wistar rats were subjected to left spinal cord hemisection, and then divided into three groups randomly. The control group received an injection of PBS without cells, while the two other groups of rats received a transplantation of 5 × 105 CD34+ CB or BMS cells, respectively. Functional outcome was measured using the modified Tarlov score at days 1, 7, 14, 21, and 28 after transplantation. A statistically significant improvement in functional outcome and survival rate in the experimental groups of rats was observed compared with the control group. Rats that received CD34+ CB cells achieved a better improvement in functional score than those that received BMS cells at days 7 and 14 after transplantation. Histological evaluation revealed that bromodeoxyuridine (BrdU)-labeled CD34+ CB and BMS cells survived and migrated into the injured area. Some of these cells expressed glial fibriliary acidic protein (GFAP) or neuronal nuclear antigen (NeuN). Our data demonstrate for the first time that intraspinal transplantation of human CD34+ CB cells provides benefit in function recovery after spinal cord hemisection in rats and suggest that CD34+ CB cells may be an excellent choice of cells as routine starting material of allogenic and autologous transplantations for the treatment of spinal cord injury.
AziziS. A.; StokesD.; AugelliB. J.; DiGirolamoC. D.; ProckopD. J.Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats—similarities to astrocyte grafts. Proc. Natl. Acad. Sci.USA.95(7): 3908–3913; 1998.
2.
BjorklundA.; LindvallO.Cell replacement therapies for central nervous system disorders.Nat. Neurosci.3: 537–544; 2000.
3.
BroxmeyerH. E.Primitive hematopoietic stem and progenitor cells in human umbilical cord blood: An alternative source of transplantable cells.Cancer Treat. Res.84: 139–148; 1996.
4.
BuzanskaL.; MachajE. K.; ZablovkaB.; PojdaZ.; Domanska-JanikK.Human cord blood-derived cells attain neuronal and glial features in vitro.J. Cell Sci.115: 2131–2138; 2002.
5.
ChenJ.; SanbergP. R.; LiY.; WangL.; LuM.; WillingA. E.; Sanchez-RamosJ.; ChoppM.Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats.Stroke32: 2682–2688; 2001.
6.
ChenJ. L.; LiY.; WangL.; ZhangZ.; LuD.; LuM.; ChoppM.Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats.Stroke32: 1005–1011; 2001.
7.
ChoppM.; ZhangX. H.; LiY.; RosenblumM.Spinal cord injury in rat: Treatment with bone marrow stromal cell transplantation.Neuroreport11: 3001–3005; 2000.
8.
DengW.; ObrockaM.; FischerI.; ProchopD. J.In vitro differentiation of human marrow stromal cells into early progenitors of neural cells by conditions that increase intracellular cyclic AMP.Biochem. Biophys. Res. Commun.282: 148–152; 2001.
9.
DienerP. S.; BregmanB. S.Fetal spinal cord transplants support growth of supraspinal and segmental projections after cervical spinal cord hemisection in the neonatal rat.J. Neurosci.18: 779–793; 1998.
10.
EglitisM. A.; MezeyE.Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice.Proc. Natl. Acad. Sci. USA94: 4080–4085; 1997.
11.
EricesA.; CongetP.; MinguellJ. J.Mesenchymal progenitor cells in human umbilical cord blood.Br. J. Haematol.109: 235–242; 2000.
12.
GageF. H.Cell therapy.Nature392: 18–24; 1998.
13.
GalvinK. A.; JohesD. G.Adult human neural stem cells for cell-replacement therapies in the central nervous system.Med. J. Aust.177: 316–318; 2002.
HaY.; ChoiJ. U.; YoonD. H.; YeonD. S.; LeeJ. J.; KimH.; ChoY. E.Neural phenotype expression of cultured human cord blood cells in vitro.Neuroreport12: 3523–3527; 2001.
16.
HofstetterC. P.; SchwarzE. J.; HessD.; WidenfalkJ.; El ManiraA.; ProckopD. J.; OlsonL.Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery.Proc. Natl. Acad. Sci. USA99: 2199–2204; 2002.
17.
KamencicH.; GriebeiR. W.; LyonA. W.; PatersonP. G.; JuurlinkB. H.Promoting glutathione synthesis after spinal cord trauma decreases secondary damage and promotes retention of function.FASEB J.15: 243–250; 2001.
18.
KopenG. C.; ProckopD. J.; PhinneyD. G.Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains.Proc. Natl. Acad. Sci. USA96: 10711–10716; 1999.
19.
LiY.; ChoppM.; ChenJ. L.; WangL.; GautanS. C.; XuY. X.; ZhangZ.Intrastriatal transplantation of bone marrow non-hematopoietic cells improves functional recovery after stroke in adult mice.J. Cereb. Blood Flow Metab.20: 1311–1319; 2000.
20.
LuD.; MahmoodA.; WangL.; LiY.; LuM.; ChoppM.Adult bone marrow stromal cells administration intravenously to rats after traumatic brain migrate into brain and improve neurological outcome.Neuroreport12(3): 559–563; 2001.
21.
LuD.; SanbergP. R.; MahmoodA.; LiY.; WangL.; Sanchez-RamosJ.; ChoppM.Intravenous administration of human umbilical cord blood reduces neurological deficit in the rat after traumatic brain injury.Cell Transplant.11(3): 275–281; 2002.
22.
MahmoodA.; LuD.; LiY.; ChenJ. L.; ChoppM.Intracranial bone marrow transplantation after traumatic brain injury improving functional outcome in adult rats.J. Neurosurg.94: 589–595; 2001.
23.
McDonaldJ. W.; LiuX. Z.; QuY.; LiuS.; MickeyS. K.; TuretskyD.; GottliebD. I.; ChoiD. W.Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord.Nat. Med.5: 1410–1412; 1999.
24.
MckayR.Stem cells in the central nervous system.Science276: 66–71; 1997.
SchwabM. E.Repairing the injured spinal cord.Science295: 1029–1031; 2000.
29.
TariqM.; MoraisC.; KishoreP. N.; BiaryN.; Al DeebS.; Al MoutaeryK.Neurological recovery in diabetic rats following spinal cord injury.J. Neurotrauma15: 239–251; 1998.
30.
WickelgrenI.Animal studies raise hopes for spinal cord repair.Neuroscience297: 178–181; 2002.
31.
WillingA. E.; LixianJ.; MillikenM.; PoulosS.; ZigovaT.; SongS.; HartC.; Sanchez-RamosJ.; SanbergP. R.Intravenous versus intrastriatal cord blood administration in a rodent model of stroke. J. Neurosci.Res.73(3): 296–307; 2003.
32.
WoodburyD.; SchwarzE. J.; ProckopD. J.; ProckopD. J.; BlackI. B.Adult rat and human bone marrow stromal cells differentiate into neurons.J. Neurosci. Res.61: 364–370; 2000.
33.
ZhaoZ. M.; LuS. H.; ZhangQ. J.; LiuH. Y.; YangR. C.; CaiY. L.; HanZ. C.The preliminary study on in vitro differentiation of human umbilical cord blood cells into neural cells.Chin. J. Hematol.24: 484–487; 2003.
